NCT03511066View on ClinicalTrials.gov

A Study to Evaluate the Efficacy and Safety of CT-P27 in Acute Uncomplicated Influenza A Infection

PHASE2TerminatedINTERVENTIONAL
Enrollment

228

Participants

Timeline

Start Date

December 9, 2016

Primary Completion Date

March 9, 2018

Study Completion Date

June 15, 2018

Conditions
Influenza A
Interventions
DRUG

CT-P27 90 mg/kg

Influenza A treatment drug.

DRUG

CT-P27 45 mg/kg

Influenza A treatment drug.

DRUG

Placebo

Placebo.

Trial Locations (1)

08308

Korea University Guro Hospital, Seoul

Sponsors

Lead Sponsor

Celltrion
All Listed Sponsors
lead

Celltrion

INDUSTRY

NCT03511066 - A Study to Evaluate the Efficacy and Safety of CT-P27 in Acute Uncomplicated Influenza A Infection | Biotech Hunter | Biotech Hunter